ArticleJournal of breast cancer2024

Racial/Ethnic Differences in Pathologic Complete Response to Neoadjuvant Chemotherapy and Survival Among Early-Stage, Erb-B2 Receptor Tyrosine Kinase 2-Low Breast Cancer Patients.

Jincong Q Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.